
- ISO 9001
- ISO 17025
About
Firalis SAS develops biomarker-based diagnostic kits and offers biomarker-related services from Huningue, France. It works across bioproduction, biobanking and clinical research for healthcare and research professionals. The company also supports regulatory affairs, commercialisation and research product supply.
Services
Bioproduction
Supplies critical components and handles kit production, including antibodies, standards and enzymes for RUO and IVD kits.
Kitting
Produces RUO and IVD kits under controlled quality systems for traced and reproducible batch-to-batch performance.
Distribution
Supports kit storage, stock logistics, product transportation and sales, and can run stability studies.
Regulatory affairs
Prepares and files development dossiers for CE-IVDR and FDA markets, including regulatory dossiers and meetings with authorities.
Biobank & clinical studies
Stores clinical samples, supports sample collection and treatment, and coordinates multicentric prospective clinical studies.
Clinical research & development
Initiates, coordinates and joins biomarker studies from discovery to clinical qualification, including sponsor and consortium roles.
Commercialisation Services
Provides commercialisation support covering strategy, market access and business growth.
Research products
Provides biomarker research products including ELISA kits, monoclonal antibodies, recombinant proteins and targeted RNA panels.
Assays & in vitro testing
Kit production
Produces RUO and IVD kits with traced and reproducible batch-to-batch performance.
- What to send
- Tell the biobank team the disease area, sample type and clinical data required · For contact, provide company or institution, email, phone optional, and message · Tell the biobank team the disease area, sample type and clinical data needed. · For products, send the products and quantities needed for a quotation.
Capabilities
- Assays and studies
- ELISA · Antibodies · Sandwich immunoassays · Immunoassays · Molecular biology assays · Targeted sequencing · Molecular biology · Hybrid principles · Direct ELISA · Indirect ELISA · ELISA-like kits
- Scale and capacity
- Several thousand square metres of automated production facility · 60 healthy volunteers · 50,000 participants · 60 healthy volunteers in HVCS · 50,000 participants in Alzevit
- Therapeutic areas
- Cardiovascular disease · Neurology · Neurodegenerative disorders · Inflammatory diseases · Autoimmune diseases · Cancer · Heart failure · Coronary heart disease · Vascular disease · Alzheimer's disease · Schizophrenia · Colorectal cancer
2 more
Cardiac disorders · Toxicities
Modalities and species
- Modalities
- Antibody · Recombinant protein
- Species and models
- Human samples · Healthy volunteers · Blood · Urine · Saliva · Buccal cells
Certifications
As the company states them, with the certificate or registry record where there is one.
ISO 13485Self-reported
Scope: medical device manufacture and kit production
ISO/IEC 17025Self-reported
Scope: testing
ISO 14001Self-reported
As listed: ISO 14001:2015 (Environmental management)
ISO 9001Self-reported
As listed: ISO 9001:2015 (Quality management system)
Industries served
- Biotech
- Medical devices
- Healthcare
- Research
Company
- Founded
- 2008
Locations
- Based in
- Huningue, France
- Sites
- Huningue, France · Haut-Rhin, France
- Serves
- Europe, France, CE-IVDR and FDA markets, FDA markets, CE-IVDR markets
Similar labs
Work here? Claim this listing